Compound ID | 3620
Synonym(s): CXA-101 | FR264205 | CXA101 | CXA101 | FR-264205 | FR 264205
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Broad spectrum with good activity against Pseudomonas aeruginosa |
| Description: | Semisynthetic compound derived from cephalosporin; approved in combination with tazobactam |
| Institute where first reported: | Astellas Pharma (Japan); Cubist |
| Year first mentioned: | 2007 |
| Highest development stage: | Approved by FDA in 2014 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/53234134 |
| Citations: |
|